Exane Derivatives’s DT Midstream DTM Stock Holding History

Exane Derivatives’s Portfolio DTM Stock Details DTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-894	Closed	-$36.5K	–	1053
2021 Q2	$36.5K	Buy	+894	New	+$36.2K	0.01%	667

Other funds holding DTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Exane Derivatives's DTM Position: Q3 2021 in Review

Exane Derivatives sold out of DT Midstream (DTM) in Q3 2021, closing a stake of 894 shares — an estimated $36.5K sold.

Exane Derivatives first reported a position in DTM in Q2 2021 and held it in 1 quarter. The position peaked at $36.5K in Q2 2021. 384 funds tracked by Wall St. Rank hold DTM as of Q3 2021.

Exane Derivatives reported no remaining DT Midstream position as of Q3 2021 after selling out during the quarter.
Exane Derivatives sold 894 DT Midstream shares in Q3 2021, an estimated $36.5K.
Exane Derivatives first reported a position in DT Midstream in Q2 2021 and held it in 1 quarter.
Exane Derivatives's DT Midstream position peaked at $36.5K in Q2 2021.
384 funds tracked by Wall St. Rank held DT Midstream as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.